Literature DB >> 1813066

3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients.

B Valentinis1, R Silvestrini, M G Daidone, D Coradini, E Galante, A M Cerrotta, G Abolafio, L Arboit.   

Abstract

Breast cancers from 476 elderly patients, 70 years and older, operated on since 1972, were analyzed for proliferative activity, hormone receptors, and DNA content. Tumor proliferative activity, expressed as 3H-thymidine labeling index (3H-TdR LI), had a median value of 3.4%, which progressively increased from 1972 to 1990. Estrogen and progesterone receptors were present respectively in 83% and 61% of the cases; the positivity for estrogen receptors slightly increased with time. Aneuploid clones were detected in 74% of the cases, and this incidence was relatively stable during the time of observation. 3H-TdR LI, hormone receptors, and ploidy were generally unrelated to the local-regional extension of the disease in these elderly patients, in agreement with observations on cancer from younger patients. However, the absence of hormone receptors and the presence of aneuploidy were markedly indicative of fast cell proliferation. As in younger patients, these biologic findings in elderly patients could be considered as a complement to clinico-pathologic features in a 'risk-factor profile system' for treatment planning.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1813066     DOI: 10.1007/BF01833353

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

1.  Cancer incidence and survival in patients 65 years of age and older.

Authors:  A Baranovsky; M H Myers
Journal:  CA Cancer J Clin       Date:  1986 Jan-Feb       Impact factor: 508.702

2.  Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer.

Authors:  J C Gazet; C Markopoulos; H T Ford; R C Coombes; J M Bland; R C Dixon
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

3.  Wide local excision as the sole primary treatment in elderly patients with carcinoma of the breast.

Authors:  M W Reed; J M Morrison
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

4.  Breast carcinoma in elderly women: pathology, prognosis, and survival.

Authors:  G Schaefer; P P Rosen; M L Lesser; D W Kinne; E J Beattie
Journal:  Pathol Annu       Date:  1984

5.  Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trials.

Authors:  H T Mouridsen; A P Andersen; H Brincker; P Dombernowsky; C Rose; K W Andersen
Journal:  NCI Monogr       Date:  1986

Review 6.  Flow cytometry, cellular DNA content, and prognosis in human malignancy.

Authors:  D E Merkel; L G Dressler; W L McGuire
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

7.  Menopausal status and cut off levels of steroid receptor ligand binding assays in breast cancer.

Authors:  A Norgren; A H Forsberg; A Lindgren; J F Sällström
Journal:  Anticancer Res       Date:  1989 Jan-Feb       Impact factor: 2.480

8.  Cell kinetics as a prognostic indicator in node-negative breast cancer.

Authors:  R Silvestrini; M G Daidone; P Valagussa; G Di Fronzo; G Mezzanotte; G Bonadonna
Journal:  Eur J Cancer Clin Oncol       Date:  1989-08

Review 9.  Breast cancer and aging.

Authors:  J A Stewart; R S Foster
Journal:  Semin Oncol       Date:  1989-02       Impact factor: 4.929

10.  A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org 2058.

Authors:  E Ronchi; G Granata; M Brivio; D Coradini; P Miodini; G Di Fronzo
Journal:  Tumori       Date:  1986-06-30
View more
  2 in total

Review 1.  Breast cancer in the elderly.

Authors:  M Bellet; C Alonso; B Ojeda
Journal:  Postgrad Med J       Date:  1995-11       Impact factor: 2.401

2.  Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women.

Authors:  M G Daidone; A Luisi; G Martelli; E Benini; S Veneroni; G Tomasic; G De Palo; R Silvestrini
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.